Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

FlowBioCat

Financiado

Cerrado

Enzymatic cascade biotransformations in digitally manufactured continuous-flow b...

Enzymatic cascade biotransformations in digitally manufactured continuous-flow bioreactors Within Industrial Biotechnology, applied biocatalysis is poised to transform drug discovery and development by pharmaceutical industry. Enzymes as catalysts, allow for synthetic chemists to generate molecular complexity avoiding c... ver más

15/01/2025

FUEUJI

165K€

Presupuesto del proyecto: 165K€

Líder del proyecto

UNIVERSITAT JAUME I DE CASTELLÓ No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 2

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2025-01-15

HORIZON-MSCA-2021-PF-01-01: MSCA Postdoctoral Fellowships 2021 ExpectedOutcome:

I+D

Cerrada hace 3 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

FUEUJI

165.31K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

BIO2017-85522-R PREDICCION Y DISEÑO DE ENZIMAS COMERCIALMENTE EXPLOTABLES 218K€ Cerrado

CTQ2011-28398-C02-01 NUEVAS ALTERNATIVAS PARA LA PRODUCCION MICROBIANA DE ENZIMAS... 149K€ Cerrado

BIO2015-66426-R INGENIERIA Y EVOLUCION DE ENZIMAS DE NOVO CON ACTIVIDADES NO... 399K€ Cerrado

PCIN-2016-129 PROCESOS CON ISOMERASAS TERMOESTABLES PARA BIOTECNOLOGIA 197K€ Cerrado

BIOSUSAMIN The design and development of efficient biocatalytic cascade... 1M€ Cerrado

BIOINTENSE Mastering bioprocess Integration and intensification across... 7M€ Cerrado

Duración del proyecto: 29 meses Fecha Inicio: 2022-08-10
Fecha Fin: 2025-01-15

Líder del proyecto

UNIVERSITAT JAUME I DE CASTELLÓ No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 2

Presupuesto del proyecto 165K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Within Industrial Biotechnology, applied biocatalysis is poised to transform drug discovery and development by pharmaceutical industry. Enzymes as catalysts, allow for synthetic chemists to generate molecular complexity avoiding costly and time-consuming protection and deprotection steps. However, the high cost associated to their use, especially if a co-factor is required, the low substrate tolerance and productivity and the difficulties for scale-up, strongly limit the industrial uptake of these processes. The combination of enzyme immobilisation and continuous flow (CF), offers an opportunity to overcome these limitations. Enzymatic performance and recyclability can be dramatically improved by immobilisation and generic problems such as low productivity and substrate inhibition effect can be solved using CF. During the last years, enzymes have been most commonly immobilised in packed bed reactors. However, the very low flow rates required to achieve full conversion, decrease the mixing and make the system look closer to a batch reaction (with its generic problems). Here we aim to address these limitations through the design and manufacture of 3D Printed (3DP) reactors that combine optimised mixing at low flow rates, with tailored surface modification techniques with ionic liquids (ILs) for stable biocatalyst preparation and higher number of active sites. 3DP facilitates the generation of complex geometries in a variety of materials based on ILs, tailored to optimise enzyme stability. The aim of this proposal is to integrate chemical engineering (3DP continuous flow reactors) and biocatalysis (stable and recyclable immobilised enzymes) to develop more efficient biotransformations in flow, easy and effective immobilisation of enzymes and significantly promote sustainable development of IB. It will have a direct impact in the EU from an environmental, economic and social perspective, lowering drug prices, facilitating distributed production and reducing waste.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores